As Chief Strategy and Transformation Officer at Emergent BioSolutions, Stephanie Duatschek leads corporate strategy, business development, and M&A. With over 25 years in biopharma and an MBA from Duke University, she integrates R&D and commercial operations to drive growth. Colleagues describe her as a respected, analytical, and collaborative leader.
Stephanie is also an adjunct lecturer at Georgetown University, where she teaches a course on commercialization for the biotechnology industry. She is a listed donor for The Lab School of Washington, indicating an interest in supporting educational institutions.
She chairs both the Product Development and M&A Committees at Emergent, placing her at the center of the companys future growth decisions.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.